916210-69-0Relevant academic research and scientific papers
HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE
-
Page/Page column 83-84, (2009/10/22)
The present invention relates to compounds and methods which may be useful as inhibitors of GPR119 for the treatment or prevention of metabolic, cardiovascular, and metabolic diseases.
HETEROBICYCLIC METALLOPROTEASE INHIBITORS
-
Page/Page column 194, (2008/06/13)
The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP- 13 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP- 13 inhibitors.
